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infrared cameras of the ExacTrac® system for automatice treatment position. IGRT is performed before each treatment ﬁeld. The
6D robotic couch allows translational and rotational corrections. Sliding Windows IMRT treatment is administered with multiple
coplanar beams.
Results. FromNovember/2008 to January/2013,wehave treated 17patientswith 22 spinemetastasis, all the patients received single
18Gy, GTV is contoured as the entire body of the vertebra and/or the affected transverse and spinous processes, PTV is obtained
by expanding 2–3mm GTV. OARs dose constrains are based on RTOG-0631 protocol. The location of the vertebral metastasis
was: cervical 5, thoracic 9, lumbar 8; none of the patients have had prior radiotherapy on the treatment ﬁeld. 8 patients (47.05%)
have pain VAS≥5. With a median follow up of 17.6 months (0.5–43.5), 20 tumors had local control after treatment. No grade III
toxicity was found, total pain control was achieved in 70% of the patients, with a pain reduction in 90% (median months from
the treatment 3.8 weeks).
Conclusions. Vertebral radiosurgery is safe an accurate for spinal metastases, achieving fast and good results in pain and tumoral
control.
http://dx.doi.org/10.1016/j.rpor.2013.03.554
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Purpose. To present preliminary experience in the treatment of CNS metastases with radiosurgery, using multiple non-coplanar
arcs with RapidArc®.
Methods. From June to December 2012 ten patients were included (7 patients with single mts, 2 with two mts, and one pts with
4 mts). Mean age was 65 yo. (57–79). Primary tumour was: lung 6, breast 2, colon 1, prostate 1. ECOG distribution: 0:1; 1:5; 2:3;
3:1. Only two patients have evidence of metastases outside of CNS with minimal burden. Immobilization was performed with
thermoplastic mask and CT simulation with slices of 1.5mm. Treatment consists of 4–5 non-coplanar arcs (VMAT) with different
table rotation (0, 60, 30, 330 and 360◦). Prescription dose ranged from 12 to 18Gy. Dosimetric objectives were: 99% of PTV and 100%
of GTV must received 100% of prescription dose. Quality of treatment planning was evaluated with Paddick index, homogeneity
index and gradient index. Geometric veriﬁcation was made with cone beam CT. Median PTV was 6.6 cm3 (0.4–36 cm3).
Results. Dosimetric results: Quality index were superior compared to other techniques (cones, tomotherapy, and cyberknife).
Total treatment time (median): 29 + 8min. Clinical results: Acute toxicity: there were two case of mild hemiparesia, and one
case of headache. Local control: only one patient showed local progression. Regional control: two patients developed other
CNS metastases and were rescued with another radiosurgery, and one patient developed multiple CNS metastases requiring
holocraneal irradiation. Three patients were deceased because of disease progression. Seven patients were alive after a mean
follow-up of 17 weeks.
Conclusions. Single fraction radiosurgery with RapidArc® with multiple non-coplanar arcs showed high accuracy and quality.
Toxicity was mild and early results are comparable with other radiosurgery techniques.
http://dx.doi.org/10.1016/j.rpor.2013.03.555
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Purpose. Several recent studies have shown that a subset of patients with metastatic cancer in limited organs may beneﬁt from
metastasis-directed therapy.
Aim. We present a series on patients treated with stereotactic tomotherapy (HT), and assess the efﬁcacy and toxicity of this new
technology in the treatment of extracraneal oligometastasis.
Materials and methods. From August 2006 through July 2011, 42 consecutive patients (median age 69 years) with 1–3 metastatic
cancer sites receivedHT to all known cancer sites (lung, n=28; liver, n=12; adrenal, n=2). Twenty-seven patients (64%) had a single
lesion, 12 patients (29%) 2 lesions, and 3 patients (7%) 3 lesions. Acute toxicities were scored using the Common Terminology
Criteria version 3.0.
Results. A total of 60 lesions were treated with hypofractionated HT (median dose 39Gy [range 36–72.5]; median dose per fraction
12Gy [range, 5–20]). With a median follow-up period of 15 months (range 2–57), 1- and 2-year overall survival (OS) was 84%
and 63%, respectively; and 1- and 2-year local control (LC) was 92% and 86%, respectively. Regarding treatment-related acute
